J Benítez|A LLerena|J Cobaleda - JoVE Visualize

Showing results (1-10 of 377) with videos related to

Pageof 38

Sort By:

Clinical Pharmacology and Therapeutics|July 1, 1988

Debrisoquin oxidation polymorphism in a Spanish populationJ Benítez, A LLerena, J Cobaleda

European Journal of Drug Metabolism and Pharmacokinetics|April 1, 1996

Interethnic differences in drug metabolism: influence of genetic and environmental factors on debrisoquine hydroxylation phenotypeA Llerena, J Cobaleda, C Martínez, et al.

Acta Psychiatrica Scandinavica|January 1, 1993

Relationship between personality and debrisoquine hydroxylation capacity. Suggestion of an endogenous neuroactive substrate or product of the cytochrome P4502D6A Llerena, G Edman, J Cobaleda, et al.

European Journal of Cancer (Oxford, England : 1990)|January 1, 1991

Polymorphic oxidation of debrisoquine in lung cancer patientsJ Benítez, J M Ladero, C Jara, et al.

Clinical Pharmacology and Therapeutics|December 1, 1993

Debrisoquin and mephenytoin hydroxylation phenotypes and CYP2D6 genotype in patients treated with neuroleptic and antidepressant agentsA LLerena, A G Herraíz, J Cobaleda, et al.

Annals of Medicine|June 1, 1990

Polymorphic oxidation of debrisoquine in bladder cancerJ Benítez, J M Ladero, M J Fernández-Gundín, et al.

Pharmacology & Toxicology|July 1, 1993

Reproducibility over time of mephenytoin and debrisoquine hydroxylation phenotypesA Llerena, M J Valdivielso, J Benítez, et al.

Fundamental & Clinical Pharmacology|July 20, 2007

Increased risk for major depression associated with the short allele of the serotonin transporter promoter region (5-HTTLPR-S) and the CYP2C9*3 alleleP Dorado, E M Peñas-Lledó, A P González, et al.

Anales De Medicina Interna (Madrid, Spain : 1984)|February 1, 1991

[Acetylation polymorphism in lung cancer]J M Laredo Quesada, C Jara Sánchez, J Benítez Rodríguez, et al.

The Pharmacogenomics Journal|June 9, 2016

High frequency of CYP2D6 ultrarapid metabolizers in Spain: controversy about their misclassification in worldwide population studiesM E G Naranjo, F de Andrés, A Delgado, et al.

Pageof 38

Showing results (1-10 of 377) with videos related to

Sort By:

Pageof 38

Clinical Pharmacology and Therapeutics|July 1, 1988

Debrisoquin oxidation polymorphism in a Spanish populationJ Benítez, A LLerena, J Cobaleda

European Journal of Drug Metabolism and Pharmacokinetics|April 1, 1996

Interethnic differences in drug metabolism: influence of genetic and environmental factors on debrisoquine hydroxylation phenotypeA Llerena, J Cobaleda, C Martínez, et al.

Acta Psychiatrica Scandinavica|January 1, 1993

Relationship between personality and debrisoquine hydroxylation capacity. Suggestion of an endogenous neuroactive substrate or product of the cytochrome P4502D6A Llerena, G Edman, J Cobaleda, et al.

European Journal of Cancer (Oxford, England : 1990)|January 1, 1991

Polymorphic oxidation of debrisoquine in lung cancer patientsJ Benítez, J M Ladero, C Jara, et al.

Clinical Pharmacology and Therapeutics|December 1, 1993

Debrisoquin and mephenytoin hydroxylation phenotypes and CYP2D6 genotype in patients treated with neuroleptic and antidepressant agentsA LLerena, A G Herraíz, J Cobaleda, et al.

Annals of Medicine|June 1, 1990

Polymorphic oxidation of debrisoquine in bladder cancerJ Benítez, J M Ladero, M J Fernández-Gundín, et al.

Pharmacology & Toxicology|July 1, 1993

Reproducibility over time of mephenytoin and debrisoquine hydroxylation phenotypesA Llerena, M J Valdivielso, J Benítez, et al.

Fundamental & Clinical Pharmacology|July 20, 2007

Increased risk for major depression associated with the short allele of the serotonin transporter promoter region (5-HTTLPR-S) and the CYP2C9*3 alleleP Dorado, E M Peñas-Lledó, A P González, et al.

Anales De Medicina Interna (Madrid, Spain : 1984)|February 1, 1991

[Acetylation polymorphism in lung cancer]J M Laredo Quesada, C Jara Sánchez, J Benítez Rodríguez, et al.

The Pharmacogenomics Journal|June 9, 2016

High frequency of CYP2D6 ultrarapid metabolizers in Spain: controversy about their misclassification in worldwide population studiesM E G Naranjo, F de Andrés, A Delgado, et al.

Pageof 38